-
1
-
-
0142200403
-
Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin
-
I. Bedendi, G. Alloatti, A. Marcantoni, D. Malan, F. Catapano, and C. Ghé Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin Eur J Pharmacol 476 2003 87 95
-
(2003)
Eur J Pharmacol
, vol.476
, pp. 87-95
-
-
Bedendi, I.1
Alloatti, G.2
Marcantoni, A.3
Malan, D.4
Catapano, F.5
Ghé, C.6
-
2
-
-
0037013178
-
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
-
V. Bodart, M. Febbraio, A. Demers, N. McNicoll, P. Pohankova, and A. Perreault CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart Circ Res 90 2002 844 849
-
(2002)
Circ Res
, vol.90
, pp. 844-849
-
-
Bodart, V.1
Febbraio, M.2
Demers, A.3
McNicoll, N.4
Pohankova, P.5
Perreault, A.6
-
3
-
-
0141923119
-
Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans
-
M. Enomoto, N. Nagaya, M. Uematsu, H. Okumura, E. Nakagawa, and F. Ono Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans Clin Sci (Lond) 105 2003 431 435
-
(2003)
Clin Sci (Lond)
, vol.105
, pp. 431-435
-
-
Enomoto, M.1
Nagaya, N.2
Uematsu, M.3
Okumura, H.4
Nakagawa, E.5
Ono, F.6
-
4
-
-
0242383502
-
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart
-
S. Frascarelli, S. Ghelardoni, S. Ronca-Testoni, and R. Zucchi Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart Basic Res Cardiol 98 2003 401 405
-
(2003)
Basic Res Cardiol
, vol.98
, pp. 401-405
-
-
Frascarelli, S.1
Ghelardoni, S.2
Ronca-Testoni, S.3
Zucchi, R.4
-
5
-
-
3042735648
-
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans
-
S. Gnanapavan, B. Kola, S.A. Bustin, D.G. Morris, P. McGee, and P. Fairclough The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans J Clin Endocrinol Metab 87 2002 2988
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 2988
-
-
Gnanapavan, S.1
Kola, B.2
Bustin, S.A.3
Morris, D.G.4
McGee, P.5
Fairclough, P.6
-
6
-
-
70449656984
-
Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect
-
C.X. Huang, M.J. Yuan, H. Huang, G. Wu, Y. Liu, and S.B. Yu Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect Peptides 30 2009 2286 2291
-
(2009)
Peptides
, vol.30
, pp. 2286-2291
-
-
Huang, C.X.1
Yuan, M.J.2
Huang, H.3
Wu, G.4
Liu, Y.5
Yu, S.B.6
-
7
-
-
2442515963
-
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes
-
M.J. Iglesias, R. Piñeiro, M. Blanco, R. Gallego, C. Diéguez, and O. Gualillo Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes Cardiovasc Res 62 2004 481 488
-
(2004)
Cardiovasc Res
, vol.62
, pp. 481-488
-
-
Iglesias, M.J.1
Piñeiro, R.2
Blanco, M.3
Gallego, R.4
Diéguez, C.5
Gualillo, O.6
-
8
-
-
0036123510
-
Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
-
P.L. Jeffery, A.C. Herington, and L.K. Chopin Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines J Endocrinol 172 2002 R7 11
-
(2002)
J Endocrinol
, vol.172
, pp. 7-11
-
-
Jeffery, P.L.1
Herington, A.C.2
Chopin, L.K.3
-
9
-
-
0033540056
-
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
-
M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
-
(1999)
Nature
, vol.402
, pp. 656-660
-
-
Kojima, M.1
Hosoda, H.2
Date, Y.3
Nakazato, M.4
Matsuo, H.5
Kangawa, K.6
-
10
-
-
77954591294
-
Ghrelin: More than endogenous growth hormone secretagogue
-
M. Kojima, and K. Kangawa Ghrelin: more than endogenous growth hormone secretagogue Ann N Y Acad Sci 1200 2010 140 148
-
(2010)
Ann N y Acad Sci
, vol.1200
, pp. 140-148
-
-
Kojima, M.1
Kangawa, K.2
-
11
-
-
33646231528
-
Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats
-
L. Li, L.K. Zhang, Y.Z. Pang, C.S. Pan, Y.F. Qi, and L. Chen Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats Acta Pharmacol Sin 27 2006 527 535
-
(2006)
Acta Pharmacol Sin
, vol.27
, pp. 527-535
-
-
Li, L.1
Zhang, L.K.2
Pang, Y.Z.3
Pan, C.S.4
Qi, Y.F.5
Chen, L.6
-
12
-
-
67749084358
-
Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation
-
L.H. Lund, J.J. Williams, P. Freda, J.J. LaManca, T.H. LeJemtel, and D.M. Mancini Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation Eur J Heart Fail 11 2009 789 794
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 789-794
-
-
Lund, L.H.1
Williams, J.J.2
Freda, P.3
Lamanca, J.J.4
Lejemtel, T.H.5
Mancini, D.M.6
-
13
-
-
20844460120
-
Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
-
N. Nagaya, J. Moriya, Y. Yasumura, M. Uematsu, F. Ono, and W. Shimizu Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure Circulation 110 2004 3674 3679
-
(2004)
Circulation
, vol.110
, pp. 3674-3679
-
-
Nagaya, N.1
Moriya, J.2
Yasumura, Y.3
Uematsu, M.4
Ono, F.5
Shimizu, W.6
-
14
-
-
0035908954
-
Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure
-
N. Nagaya, M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, and W. Shimizu Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure Circulation 104 2001 1430 1435
-
(2001)
Circulation
, vol.104
, pp. 1430-1435
-
-
Nagaya, N.1
Uematsu, M.2
Kojima, M.3
Ikeda, Y.4
Yoshihara, F.5
Shimizu, W.6
-
15
-
-
0037784049
-
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure
-
N. Nagaya, and K. Kangawa Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure Regul Pept 114 2003 71 77
-
(2003)
Regul Pept
, vol.114
, pp. 71-77
-
-
Nagaya, N.1
Kangawa, K.2
-
16
-
-
0035940390
-
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: Relationships between ghrelin and anabolic/catabolic factors
-
N. Nagaya, M. Uematsu, M. Kojima, Y. Date, M. Nakazato, and H. Okumura Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors Circulation 104 2001 2034 2038
-
(2001)
Circulation
, vol.104
, pp. 2034-2038
-
-
Nagaya, N.1
Uematsu, M.2
Kojima, M.3
Date, Y.4
Nakazato, M.5
Okumura, H.6
-
17
-
-
0033756755
-
Growth hormone secretagogue binding sites in peripheral human tissues
-
M. Papotti, C. Ghe, P. Cassoni, F. Catapano, R. Deghenghi, and E. Ghigo Growth hormone secretagogue binding sites in peripheral human tissues J Clin Endocrinol Metab 85 2000 3803 3807
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 3803-3807
-
-
Papotti, M.1
Ghe, C.2
Cassoni, P.3
Catapano, F.4
Deghenghi, R.5
Ghigo, E.6
-
18
-
-
38949117904
-
Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors
-
S. Perez, L.J. Royo, A. Astudillo, D. Escudero, F. Alvarez, and A. Rodriguez Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors BMC Mol Biol 8 2007 114
-
(2007)
BMC Mol Biol
, vol.8
, pp. 114
-
-
Perez, S.1
Royo, L.J.2
Astudillo, A.3
Escudero, D.4
Alvarez, F.5
Rodriguez, A.6
-
19
-
-
35748945164
-
Ghrelin localization in the medulla of rat and human adrenal gland and in pheochromocytomas
-
K. Raghay, T. Garcia-Caballero, S. Bravo, C.V. Alvarez, R. Gonzalez, and C. Dieguez Ghrelin localization in the medulla of rat and human adrenal gland and in pheochromocytomas Histol Histopathol 23 2008 57 65
-
(2008)
Histol Histopathol
, vol.23
, pp. 57-65
-
-
Raghay, K.1
Garcia-Caballero, T.2
Bravo, S.3
Alvarez, C.V.4
Gonzalez, R.5
Dieguez, C.6
-
20
-
-
77149180432
-
Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome
-
A. Rodriguez, J. Gomez-Ambrosi, V. Catalan, S. Becerril, N. Sainz, and M.J. Gil Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome J Hypertens 28 2010 560 567
-
(2010)
J Hypertens
, vol.28
, pp. 560-567
-
-
Rodriguez, A.1
Gomez-Ambrosi, J.2
Catalan, V.3
Becerril, S.4
Sainz, N.5
Gil, M.J.6
-
21
-
-
33744980877
-
Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels
-
J.B. Soares, A. Rocha-Sousa, P. Castro-Chaves, T. Henriques-Coelho, and A.F. Leite-Moreira Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels Peptides 27 2006 1616 1623
-
(2006)
Peptides
, vol.27
, pp. 1616-1623
-
-
Soares, J.B.1
Rocha-Sousa, A.2
Castro-Chaves, P.3
Henriques-Coelho, T.4
Leite-Moreira, A.F.5
-
22
-
-
77956552524
-
Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure
-
F. Weis, A. Beiras-Fernandez, R. Sodian, I. Kaczmarek, B. Reichart, and A. Beiras Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure J Mol Cell Cardiol 48 2010 1187 1193
-
(2010)
J Mol Cell Cardiol
, vol.48
, pp. 1187-1193
-
-
Weis, F.1
Beiras-Fernandez, A.2
Sodian, R.3
Kaczmarek, I.4
Reichart, B.5
Beiras, A.6
-
23
-
-
0036687932
-
Comparison of vasodilators in human internal mammary artery: Ghrelin is a potent physiological antagonist of endothelin-1
-
K.E. Wiley, and A.P. Davenport Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1 Br J Pharmacol 136 2002 1146 1152
-
(2002)
Br J Pharmacol
, vol.136
, pp. 1146-1152
-
-
Wiley, K.E.1
Davenport, A.P.2
-
24
-
-
25444519434
-
GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure
-
X.B. Xu, J.J. Pang, J.M. Cao, C. Ni, R.K. Xu, and X.Z. Peng GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure Am J Physiol Heart Circ Physiol 289 2005 H1643 H1651
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
-
-
Xu, X.B.1
Pang, J.J.2
Cao, J.M.3
Ni, C.4
Xu, R.K.5
Peng, X.Z.6
|